Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,532 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fibroblast Activation Protein Inhibitor Theranostics: The Case for Use in Sarcoma.
Hamacher R, Lanzafame H, Mavroeidi IA, Pabst KM, Kessler L, Cheung PF, Bauer S, Herrmann K, Schildhaus HU, Siveke JT, Fendler WP. Hamacher R, et al. Among authors: bauer s. PET Clin. 2023 Jul;18(3):361-367. doi: 10.1016/j.cpet.2023.02.008. Epub 2023 Mar 28. PET Clin. 2023. PMID: 36997366 Review.
HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostat.
Angelika Ihle M, Merkelbach-Bruse S, Hartmann W, Bauer S, Ratner N, Sonobe H, Nishio J, Larsson O, Åman P, Pedeutour F, Taguchi T, Wardelmann E, Buettner R, Schildhaus HU. Angelika Ihle M, et al. Among authors: bauer s. J Pathol Clin Res. 2016 Feb 5;2(2):59-71. doi: 10.1002/cjp2.35. eCollection 2016 Apr. J Pathol Clin Res. 2016. PMID: 27499916 Free PMC article.
Preclinical models for translational sarcoma research.
Hamacher R, Bauer S. Hamacher R, et al. Among authors: bauer s. Curr Opin Oncol. 2017 Jul;29(4):275-285. doi: 10.1097/CCO.0000000000000373. Curr Opin Oncol. 2017. PMID: 28445233 Review.
[Imatinib and beyond-what is important for surgery?].
Hamacher R, Falkenhorst J, Treckmann J, Bauer S. Hamacher R, et al. Among authors: bauer s. Chirurg. 2019 Jun;90(6):462-469. doi: 10.1007/s00104-019-0934-0. Chirurg. 2019. PMID: 30903227 Review. German.
New therapeutic agents in gastrointestinal stromal tumours.
Falkenhorst J, Hamacher R, Bauer S. Falkenhorst J, et al. Among authors: bauer s. Curr Opin Oncol. 2019 Jul;31(4):322-328. doi: 10.1097/CCO.0000000000000549. Curr Opin Oncol. 2019. PMID: 31033566 Review.
KIT-Dependent and KIT-Independent Genomic Heterogeneity of Resistance in Gastrointestinal Stromal Tumors - TORC1/2 Inhibition as Salvage Strategy.
Mühlenberg T, Ketzer J, Heinrich MC, Grunewald S, Marino-Enriquez A, Trautmann M, Hartmann W, Wardelmann E, Treckmann J, Worm K, Bertram S, Herold T, Schildhaus HU, Glimm H, Stenzinger A, Brors B, Horak P, Hohenberger P, Fröhling S, Fletcher JA, Bauer S. Mühlenberg T, et al. Among authors: bauer s. Mol Cancer Ther. 2019 Nov;18(11):1985-1996. doi: 10.1158/1535-7163.MCT-18-1224. Epub 2019 Jul 15. Mol Cancer Ther. 2019. PMID: 31308077
2,532 results